Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Ethyl L-alaninate hydrochloride is a white to off-white adhering crystalline powder with specific chemical properties that make it suitable for various applications in different industries.

1115-59-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1115-59-9 Structure
  • Basic information

    1. Product Name: Ethyl L-alaninate hydrochloride
    2. Synonyms: ALANINE ETHYL ESTER HCL;ALANINE-OET HCL;Ethyl L-alaninate hydrochloride;H-ALA-OET HCL;H-ALA-OET HYDROCHLORIDE;L-ALANINE ETHYL ESTER HCL;L-ALANINE ETHYL ESTER HYDROCHLORIDE;L-ETHYL 2-AMINOPROPANOATE HYDROCHLORIDE
    3. CAS NO:1115-59-9
    4. Molecular Formula: C5H12NO2*Cl
    5. Molecular Weight: 153.61
    6. EINECS: 214-225-9
    7. Product Categories: Amino Acids;Alanine [Ala, A];Amino Acids and Derivatives;Amino hydrochloride;Alanine;Amino Acid Derivatives;Peptide Synthesis;amino
    8. Mol File: 1115-59-9.mol
  • Chemical Properties

    1. Melting Point: 78-80 °C (dec.)(lit.)
    2. Boiling Point: 127.8 °C at 760 mmHg
    3. Flash Point: 3.5 °C
    4. Appearance: White to off-white adhering crystalline powder
    5. Density: N/A
    6. Vapor Pressure: 11mmHg at 25°C
    7. Refractive Index: N/A
    8. Storage Temp.: 0-6°C
    9. Solubility: 100g/l
    10. Sensitive: Hygroscopic
    11. BRN: 3594395
    12. CAS DataBase Reference: Ethyl L-alaninate hydrochloride(CAS DataBase Reference)
    13. NIST Chemistry Reference: Ethyl L-alaninate hydrochloride(1115-59-9)
    14. EPA Substance Registry System: Ethyl L-alaninate hydrochloride(1115-59-9)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: N/A
    3. Safety Statements: 24/25
    4. WGK Germany: 3
    5. RTECS:
    6. F: 3-10
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 1115-59-9(Hazardous Substances Data)

1115-59-9 Usage

Uses

Used in Pharmaceutical Industry:
Ethyl L-alaninate hydrochloride is used as an intermediate in the synthesis of nucleoside phosphoramidates, which serve as antiviral agents for human immunodeficiency (HIV) and hepatitis B viruses. Its role in the synthesis process is crucial for developing effective treatments against these viral infections.
Used in Chemical Synthesis:
Ethyl L-alaninate hydrochloride is also used in the synthesis of enantiomerically pure amino acid ester isocyanates. These compounds are essential in the development of various chemical products, including pharmaceuticals, agrochemicals, and other specialty chemicals. The enantiomeric purity of the amino acid ester isocyanates is vital for ensuring the desired biological activity and minimizing potential side effects.

Check Digit Verification of cas no

The CAS Registry Mumber 1115-59-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,1,1 and 5 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1115-59:
(6*1)+(5*1)+(4*1)+(3*5)+(2*5)+(1*9)=49
49 % 10 = 9
So 1115-59-9 is a valid CAS Registry Number.
InChI:InChI=1/C5H11NO2.ClH/c1-3-8-5(7)4(2)6;/h4H,3,6H2,1-2H3;1H/t4-;/m1./s1

1115-59-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (A2494)  L-Alanine Ethyl Ester Hydrochloride  >98.0%(N)

  • 1115-59-9

  • 5g

  • 450.00CNY

  • Detail
  • TCI America

  • (A2494)  L-Alanine Ethyl Ester Hydrochloride  >98.0%(N)

  • 1115-59-9

  • 25g

  • 1,480.00CNY

  • Detail
  • Alfa Aesar

  • (A11271)  L-Alanine ethyl ester hydrochloride, 98+%   

  • 1115-59-9

  • 5g

  • 257.0CNY

  • Detail
  • Alfa Aesar

  • (A11271)  L-Alanine ethyl ester hydrochloride, 98+%   

  • 1115-59-9

  • 25g

  • 1013.0CNY

  • Detail
  • Aldrich

  • (855669)  L-Alanineethylesterhydrochloride  99%

  • 1115-59-9

  • 855669-5G

  • 305.37CNY

  • Detail
  • Aldrich

  • (855669)  L-Alanineethylesterhydrochloride  99%

  • 1115-59-9

  • 855669-25G

  • 1,188.72CNY

  • Detail

1115-59-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-Ethyl 2-aminopropanoate hydrochloride

1.2 Other means of identification

Product number -
Other names H-Ala-OEt·HCl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1115-59-9 SDS

1115-59-9Synthetic route

ethanol
64-17-5

ethanol

L-alanin
56-41-7

L-alanin

(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

Conditions
ConditionsYield
With thionyl chloride for 4h; Reflux;100%
With hydrogenchloride for 12h; Reflux;99%
With thionyl chloride99%
L-alanin
56-41-7

L-alanin

(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

Conditions
ConditionsYield
In ethanol98%
ethyl 2-nitropropanoate

ethyl 2-nitropropanoate

(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

Conditions
ConditionsYield
With hydrogenchloride; sodium tetrahydroborate In tetrahydrofuran; water at 20℃; for 2h; Inert atmosphere; Green chemistry; chemoselective reaction;91%
N-tert-butoxycarbonyl-L-alanine ethyl ester
51814-53-0

N-tert-butoxycarbonyl-L-alanine ethyl ester

(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

Conditions
ConditionsYield
With hydrogenchloride; water In 1,4-dioxane
(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

(3R,5S)-7-chloro-5-(2,3-dimethoxyphenyl)-1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetic acid
189060-51-3

(3R,5S)-7-chloro-5-(2,3-dimethoxyphenyl)-1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetic acid

ethyl N-[[(3R,5S)-7-chloro-5-(2,3-dimethoxyphenyl)-1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]acetyl]-L-alaninate
383662-10-0

ethyl N-[[(3R,5S)-7-chloro-5-(2,3-dimethoxyphenyl)-1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]acetyl]-L-alaninate

Conditions
ConditionsYield
With diethylphosphoryl cyanide; triethylamine In N,N-dimethyl-formamide at 20℃; for 0.5h;100%
(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

benzaldehyde
100-52-7

benzaldehyde

(S,E)-ethyl 2-(benzylideneamino)propanoate
142128-23-2

(S,E)-ethyl 2-(benzylideneamino)propanoate

Conditions
ConditionsYield
With triethylamine In acetonitrile100%
(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

4-chlorobenzaldehyde
104-88-1

4-chlorobenzaldehyde

L-alanine ethyl ester-p-chlorobenzyl shiff base

L-alanine ethyl ester-p-chlorobenzyl shiff base

Conditions
ConditionsYield
With triethylamine In ethanol at 20℃; for 2h;100%
With triethylamine In ethanol at 20 - 60℃; for 2h;100%
(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

3-[(S)-2-carboxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl]indole-1-carboxylic acid tert-butyl ester
143824-78-6

3-[(S)-2-carboxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl]indole-1-carboxylic acid tert-butyl ester

C36H39N3O7
1578249-27-0

C36H39N3O7

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 24h; Reagent/catalyst; Solvent; Inert atmosphere;100%
(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

methylamine
74-89-5

methylamine

(S)-2-amino-N-methyl-propionamide
33194-35-3

(S)-2-amino-N-methyl-propionamide

Conditions
ConditionsYield
In water for 0.5h;99%
In ethanol at 20℃; for 48h;90%
In ethanol at 20℃; for 48h;90%
(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

4-chlorophenylphosphorodichloridate
772-79-2

4-chlorophenylphosphorodichloridate

ethyl N-[chloro(4-chlorophenoxy)phosphoryl]-L-alaninate
840506-39-0

ethyl N-[chloro(4-chlorophenoxy)phosphoryl]-L-alaninate

Conditions
ConditionsYield
With triethylamine In dichloromethane at -78 - 20℃;99%
With triethylamine In dichloromethane at -78 - 20℃;
In dichloromethane Alkaline conditions;
N-phenyl-N-methylcarbamoyl chloride
4285-42-1

N-phenyl-N-methylcarbamoyl chloride

(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

(S)-ethyl 2-(3-methyl-3-phenylureido)propanoate

(S)-ethyl 2-(3-methyl-3-phenylureido)propanoate

Conditions
ConditionsYield
With triethylamine In acetonitrile for 20h; Reflux;99%
(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

2,3,6-tri-O-acetyl-4-O-[2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl]-β-D-glucopyranosyl isothiocyanate
77489-36-2, 81319-58-6, 99945-30-9, 81319-57-5

2,3,6-tri-O-acetyl-4-O-[2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl]-β-D-glucopyranosyl isothiocyanate

N-{[(2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl)-(1→4)-2,3,6-tri-O-acetyl-β-D-glucopyranosylamino]thioxomethyl}alanine ethyl ester
1353744-44-1

N-{[(2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl)-(1→4)-2,3,6-tri-O-acetyl-β-D-glucopyranosylamino]thioxomethyl}alanine ethyl ester

Conditions
ConditionsYield
With pyridine In benzene at 20℃; for 5h;98.3%
(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

L-Alanine ethyl ester
3082-75-5

L-Alanine ethyl ester

Conditions
ConditionsYield
With triethylamine In chloroform at 20℃; for 7h; Reflux;98%
With triethylamine In water at 20℃; for 0.5h;86%
With sodium hydroxide In dichloromethane at 20℃; for 0.166667h;60%
4-iodobenzoic acid
619-58-9

4-iodobenzoic acid

(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

N-(4-iodobenzoyl)-L-alanine ethyl ester
1072115-61-7

N-(4-iodobenzoyl)-L-alanine ethyl ester

Conditions
ConditionsYield
Stage #1: 4-iodobenzoic acid With benzotriazol-1-ol; 1,2-dichloro-ethane In dichloromethane at 20℃; for 0.166667h;
Stage #2: (S)-alanine ethyl ester hydrochloride With triethylamine In dichloromethane at 0 - 20℃;
98%
(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

benzyl bromide
100-39-0

benzyl bromide

(S)-ethyl 2-(dibenzylamino)propanoate
171815-89-7

(S)-ethyl 2-(dibenzylamino)propanoate

Conditions
ConditionsYield
With potassium carbonate In acetonitrile at 70℃; for 14h;98%
6-(2-methoxyphenyl)pyrimidin-4-amine
1142004-97-4

6-(2-methoxyphenyl)pyrimidin-4-amine

(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

2-{3-[6-(2-methoxy-phenyl)-pyrimidin-4-yl]-ureido}-propionic acid ethyl ester
1142005-76-2

2-{3-[6-(2-methoxy-phenyl)-pyrimidin-4-yl]-ureido}-propionic acid ethyl ester

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; phenyl chloroformate In 1,4-dioxane; dichloromethane at -78 - 70℃;97.8%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

Boc-Val-Ala-OEt

Boc-Val-Ala-OEt

Conditions
ConditionsYield
Stage #1: (S)-alanine ethyl ester hydrochloride With triethylamine In dichloromethane
Stage #2: t-Boc-L-valine In dichloromethane at 25℃; Inert atmosphere;
97%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 0℃;
(E)-3-phenyl-2-pentenoic acid
1528-58-1

(E)-3-phenyl-2-pentenoic acid

(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

ethyl (E)-(3-phenylpent-2-enoyl)-L-alaninate

ethyl (E)-(3-phenylpent-2-enoyl)-L-alaninate

Conditions
ConditionsYield
Stage #1: (E)-3-phenyl-2-pentenoic acid With dmap In dichloromethane at 0℃; for 0.25h;
Stage #2: (S)-alanine ethyl ester hydrochloride With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0 - 20℃; for 6h;
97%
2,3-Dichloro-1,4-naphthoquinone
117-80-6

2,3-Dichloro-1,4-naphthoquinone

(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

(S)-(+)-N-3-(chloro-1,4-naphthoquinon-2-yl)alanine ethyl ester
909797-05-3

(S)-(+)-N-3-(chloro-1,4-naphthoquinon-2-yl)alanine ethyl ester

Conditions
ConditionsYield
With potassium carbonate In ethanol at 110℃; for 3h;96%
(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

4-methoxy-aniline
104-94-9

4-methoxy-aniline

1H-imidazole-1-carbodithioic acid methyl ester
74734-11-5

1H-imidazole-1-carbodithioic acid methyl ester

(S)-3-(4-methoxyphenyl)-5-methyl-2-thioxoimidazolidin-4-one

(S)-3-(4-methoxyphenyl)-5-methyl-2-thioxoimidazolidin-4-one

Conditions
ConditionsYield
With triethylamine In ethanol Heating;96%
(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

cyclopropanecarboxylic acid chloride
4023-34-1

cyclopropanecarboxylic acid chloride

2-(cyclopropanecarbonyl-amino)-propionic acid ethyl ester
885339-39-9

2-(cyclopropanecarbonyl-amino)-propionic acid ethyl ester

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃;96%
N-Cbz-L-Phe
1161-13-3

N-Cbz-L-Phe

(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

Z-Phe-Ala-OEt
60644-13-5

Z-Phe-Ala-OEt

Conditions
ConditionsYield
Stage #1: (S)-alanine ethyl ester hydrochloride With sodium carbonate
Stage #2: N-Cbz-L-Phe With dmap; dicyclohexyl-carbodiimide In dichloromethane at 4 - 20℃; for 1.58333h;
95%
With 2,6-dimethylpyridine; 1-[(1-(cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino)]-uronium hexafluorophosphate In water at 20 - 25℃;85%
(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

2-Bromoacetyl bromide
598-21-0

2-Bromoacetyl bromide

A

L-2-(2-bromo-acetylamino)-propionic acid ethyl ester
1127352-23-1

L-2-(2-bromo-acetylamino)-propionic acid ethyl ester

B

(S)-N-(2-chloroethanoyl)ethyl alanate
76385-53-0

(S)-N-(2-chloroethanoyl)ethyl alanate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 15h; Inert atmosphere; Overall yield = 67 %; Overall yield = 6.38 g;A 95%
B 5%
(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl isothiocyanate
14152-97-7

2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl isothiocyanate

N-[(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosylamino)thioxomethyl]alanine ethyl ester
1353744-32-7

N-[(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosylamino)thioxomethyl]alanine ethyl ester

Conditions
ConditionsYield
With pyridine In benzene at 20℃; for 5h;93.7%
(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

2-nitrophenylsulphenyl-L-isoleucine dicyclohexylammonium salt
10382-52-2

2-nitrophenylsulphenyl-L-isoleucine dicyclohexylammonium salt

Nps-Ile-Ala-OEt
97305-67-4

Nps-Ile-Ala-OEt

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In chloroform 1)-10 deg C, 2 h; 2) 2 h, room temperature;93%
(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

4-Carboxybenzaldehyde
619-66-9

4-Carboxybenzaldehyde

C13H15NO4
1349769-94-3

C13H15NO4

Conditions
ConditionsYield
Stage #1: 4-Carboxybenzaldehyde With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane
Stage #2: (S)-alanine ethyl ester hydrochloride In dichloromethane at 0 - 20℃; for 16h;
93%
(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

benzaldehyde
100-52-7

benzaldehyde

ethyl N-benzylidenealaninate
60855-77-8

ethyl N-benzylidenealaninate

Conditions
ConditionsYield
Stage #1: (S)-alanine ethyl ester hydrochloride With magnesium sulfate; triethylamine In dichloromethane at 20℃; for 1h; Inert atmosphere;
Stage #2: benzaldehyde In dichloromethane at 20℃; Inert atmosphere;
93%
Stage #1: (S)-alanine ethyl ester hydrochloride With triethylamine In dichloromethane at 20℃; Inert atmosphere;
Stage #2: benzaldehyde In dichloromethane at 20℃; Inert atmosphere;
In ethanol at 100℃; for 24h; Inert atmosphere; Schlenk technique; Glovebox;
Stage #1: (S)-alanine ethyl ester hydrochloride With sodium sulfate; triethylamine In dichloromethane at 20℃; for 1h;
Stage #2: benzaldehyde In dichloromethane
(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

Fmoc-Ile-OH
71989-23-6

Fmoc-Ile-OH

(3S,6S)-3-methyl-6-((1S)-1-methylpropyl)piperazine-2,5-dione

(3S,6S)-3-methyl-6-((1S)-1-methylpropyl)piperazine-2,5-dione

Conditions
ConditionsYield
With O-(N-succinimidyl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; triethylamine In N,N-dimethyl-formamide at 50℃; for 24h; Inert atmosphere;93%
1,4-difluoro-2-nitrobenzene
364-74-9

1,4-difluoro-2-nitrobenzene

(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

ethyl 2-((4-fluoro-2-nitrophenyl)amino)propanoate
311346-76-6

ethyl 2-((4-fluoro-2-nitrophenyl)amino)propanoate

Conditions
ConditionsYield
With pyridine; triethylamine at 80℃; for 17h; Inert atmosphere;92.6%
With pyridine; triethylamine at 80℃; for 17h;74%
N-Cbz-L-Isoleucine
3160-59-6

N-Cbz-L-Isoleucine

(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

Cbz-L-Ile-L-Ala-OEt
212070-51-4

Cbz-L-Ile-L-Ala-OEt

Conditions
ConditionsYield
With benzotriazol-1-ol; O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In acetonitrile for 21h; Ambient temperature;92%
(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

O-phenyl phosphorodichloridate
770-12-7

O-phenyl phosphorodichloridate

(2S)-ethyl 2-(chloro(phenoxy)phosphorylamino)propanoate
245078-14-2

(2S)-ethyl 2-(chloro(phenoxy)phosphorylamino)propanoate

Conditions
ConditionsYield
With triethylamine In dichloromethane92%
With triethylamine In dichloromethane at -78 - 20℃; for 1.5h;84%
With triethylamine In dichloromethane at -78 - 20℃; for 2.5h;75%
(S)-alanine ethyl ester hydrochloride
1115-59-9

(S)-alanine ethyl ester hydrochloride

2,5-hexanedione
110-13-4

2,5-hexanedione

2-(2,5-dimethyl-1H-pyrrol-1-yl)propionic acid ethyl ester
1325726-63-3

2-(2,5-dimethyl-1H-pyrrol-1-yl)propionic acid ethyl ester

Conditions
ConditionsYield
Stage #1: (S)-alanine ethyl ester hydrochloride With triethylamine In tetrahydrofuran at 20℃; for 0.5h; Paal-Knorr pyrrole synthesis;
Stage #2: 2,5-hexanedione With iodine In tetrahydrofuran at 20℃; for 24h; Paal-Knorr pyrrole synthesis; optical yield given as %ee; enantioselective reaction;
92%

1115-59-9Relevant articles and documents

Silver ion-induced chiral enhancement by argentivorous molecules

Lee, Eunji,Hosoi, Yasuhiro,Temma, Honoka,Ju, Huiyeong,Ikeda, Mari,Kuwahara, Shunsuke,Habata, Yoichi

, p. 3373 - 3376 (2020)

Optically active tetra-armed cyclens with an asymmetric chiral centre in the cyclen moiety were synthesized and were shown to enhance chirality and control of enantiomers on complexation with Ag+. Binding studies of the Ag+ complex demonstrated that Ag+ preferentially interacts with electron-rich substituents over other aromatic substituents.

TRANSFORMATION OF GLYCYRRHIZIC ACID. VII. SYNTHESIS OF TRITERPENE GLYCOPEPTIDES CONTAINING ALKYL ESTERS OF L-AMINO ACIDS

Baltina, L.A.,Ryzhova, S.A.,Vasil'eva, E.V.,Tolstikov, G.A.

, p. 238 - 244 (1994)

The synthesis has been effected by the activated N-hydroxy succinimide ester method of new triterpene glycopeptides derived from glycyrrhizic acid, containing fragments of alkyl (ethyl, propyl, butyl) esters of L-amino acids.

Synthesis of 2-(5-Hydroxymethyl-2-formylpyrrol-1-yl)propionic acid lactone

Bu, Xiaolin,Li, Yueqing,Liu, Jihong,Zeng, Debin,Zhao, Weijie

, p. 194 - 197 (2012)

2-(5-Hydroxymethyl-2-formylpyrrol-1-yl)propionic acid lactone was synthesized in six steps with a 17.0% overall yield, starting from L-alanine. The synthetic route involved the Clauson-Kaas reaction, Vilsmeier reaction, and transesterification. The transesterification was the key step in the formation of the target compound.

Characterization and cytotoxicity evaluation of biocompatible amino acid esters used to convert salicylic acid into ionic liquids

Moshikur, Rahman Md.,Chowdhury, Md. Raihan,Wakabayashi, Rie,Tahara, Yoshiro,Moniruzzaman, Muhammad,Goto, Masahiro

, p. 31 - 38 (2018)

The technological utility of active pharmaceutical ingredients (APIs) is greatly enhanced when they are transformed into ionic liquids (ILs). API-ILs have better solubility, thermal stability, and the efficacy in topical delivery than solid or crystalline drugs. However, toxicological issue of API-ILs is the main challenge for their application in drug delivery. To address this issue, 11 amino acid esters (AAEs) were synthesized and investigated as biocompatible counter cations for the poorly water-soluble drug salicylic acid (Sal) to form Sal-ILs. The AAEs were characterized using 1H and 13C NMR, FTIR, elemental, and thermogravimetric analyses. The cytotoxicities of the AAE cations, Sal-ILs, and free Sal were investigated using mammalian cell lines (L929 and HeLa). The toxicities of the AAE cations greatly increased with inclusion of long alkyl chains, sulfur, and aromatic rings in the side groups of the cations. Ethyl esters of alanine, aspartic acid, and proline were selected as a low cytotoxic AAE. The cytotoxicities of the Sal-ILs drastically increased compared with the AAEs on incorporation of Sal into the cations, and were comparable to that of free Sal. Interestingly, the water miscibilities of the Sal-ILs were higher than that of free Sal, and the Sal-ILs were miscible with water at any ratio. A skin permeation study showed that the Sal-ILs penetrated through skin faster than the Sal sodium salt. These results suggest that AAEs could be used in biomedical applications to eliminate the use of traditional toxic solvents for transdermal delivery of poorly water-soluble drugs.

Evidence for the optical signalling of changes in bicarbonate concentration within the mitochondrial region of living cells

Smith, David G.,Law, Ga-Lai,Murray, Benjamin S.,Pal, Robert,Parker, David,Wong, Ka-Leung

, p. 7347 - 7349 (2011)

Image and spectral intensity from bicarbonate-selective europium(iii) probes localised in the mitochondria of cells is modulated reversibly by variation of external pCO2, and is suppressed by addition of the carbonic anhydrase inhibitor, acetazolomide.

Asymmetric Synthesis of N-Substituted α-Amino Esters from α-Ketoesters via Imine Reductase-Catalyzed Reductive Amination

Yao, Peiyuan,Marshall, James R.,Xu, Zefei,Lim, Jesmine,Charnock, Simon J.,Zhu, Dunming,Turner, Nicholas J.

supporting information, p. 8717 - 8721 (2021/03/16)

N-Substituted α-amino esters are widely used as chiral intermediates in a range of pharmaceuticals. Here we report the enantioselective biocatalyic synthesis of N-substituted α-amino esters through the direct reductive coupling of α-ketoesters and amines employing sequence diverse metagenomic imine reductases (IREDs). Both enantiomers of N-substituted α-amino esters were obtained with high conversion and excellent enantioselectivity under mild reaction conditions. In addition >20 different preparative scale transformations were performed highlighting the scalability of this system.

Novel naphthylamide derivatives as dual-target antifungal inhibitors: Design, synthesis and biological evaluation

An, Yunfei,Dong, Yue,Liu, Min,Han, Jun,Zhao, Liyu,Sun, Bin

, (2020/11/13)

Fungal infections have become a serious medical problem due to the high infection rate and the frequent emergence of drug resistance. Squalene epoxidase (SE) and 14α-demethylase (CYP51) are considered as the important antifungal targets, they can show the synergistic effect on antifungal therapy. In the study, a series of active fragments were screened through the method of De Novo Link, and these active fragments with the higher Ludi_Scores were selected, which can show the obvious binding ability with the dual targets (SE, CYP51). Subsequently, three series of target compounds with naphthyl amide scaffolds were constructed by connecting these core fragments, and their structures were synthesized. Most of compounds showed the antifungal activity in the treatment of pathogenic fungi. It was worth noting that compounds 10b-5 and 17a-2 with the excellent broad-spectrum antifungal properties also exhibited the obvious antifungal effects against drug-resistant fungi. Preliminary mechanism study has proved these target compounds can block the biosynthesis of ergosterol by inhibiting the activity of dual targets (SE, CYP51). Furthermore, target compounds 10–5 and 17a-2 with low toxicity side effects also demonstrated the excellent pharmacological effects in vivo. The molecular docking and ADMET prediction were performed, which can guide the optimization of subsequent lead compounds.

Design, synthesis and biological evaluation of novel 2-(5-aryl-1H-imidazol-1-yl) derivatives as potential inhibitors of the HIV-1 Vpu and host BST-2 protein interaction

Bode, Moira L.,Coyanis, E. Mabel,Mosebi, Salerwe,Njengele, Zikhona,Rashamuse, Thompho J.,Sayed, Yasien

, (2020/02/13)

Novel ethyl 2-(5-aryl-1H-imidazol-1-yl)-acetates 17 and propionates 18, together with their acetic acid 19 and acetohydrazide 20 derivatives, were designed and synthesized using TosMIC chemistry. Biological evaluation of these newly synthesized scaffolds in the HIV-1 Vpu- Host BST-2 ELISA assay identified seven hits (17a, 17b, 17c, 17g, 18a, 20f and 20g) with greater than 50% inhibitory activity. These hits were validated in the HIV-1 Vpu- Host BST-2 AlphaScreen and six of the seven compounds were found to have comparable percentage inhibitory activities to those of the ELISA assay. Compounds 17b and 20g, with consistent percentage inhibitory activities across the two assays, had IC50 values of 11.6 ± 1.1 μM and 17.6 ± 0.9 μM in a dose response AlphaScreen assay. In a cell-based HIV-1 antiviral assay, compound 17b exhibited an EC50 = 6.3 ± 0.7 μM at non-toxic concentrations (CC50 = 184.5 ± 0.8 μM), whereas compound 20g displayed antiviral activity roughly equivalent to its toxicity (CC50 = 159.5 ± 0.9 μM). This data suggests that compound 17b, active in both cell-based and biochemical assays, provides a good starting point for the design of possible lead compounds for prevention of HIV-1 Vpu and host BST-2 protein binding in new anti-HIV therapeutics.

Potent arylamide derivatives as dual-target antifungal agents: Design, synthesis, biological evaluation, and molecular docking studies

An, Yunfei,Dong, Yue,Han, Jun,Liu, Min,Liu, Xinyong,Sun, Bin

, (2020/03/27)

Fungal infections have become a serious medical problem due to the high infection rate and the frequent emergence of drug resistance. Ergosterol is an important structural component of the fungal cell membrane, its synthetases (squalene epoxidase (SE) and 14α-demethylase (CYP51)) are considered as the key points to block the ergosterol synthesis. In this study, we designed a series of dual-target arylamides derivatives based on the analysis of active sites (SE, CYP51). Subsequently, these target compounds were synthesized, and their antifungal activity was evaluated. Most of compounds demonstrate the potent antifungal activity against multiple Candida spp. and A. fum. In particular, the antifungal activities of compounds 10b and 11c are not only superior to positive control drugs, but also have significant inhibitory effects on drug-resistant fungi (C.alb. Strain100, C.alb. Strain103). Therefore, their action mechanism was further studied. Cellular uptake and electron microscopy observation showed that target compounds were able to enter fungal cytoplasmic region through free diffusion, and destroyed cell membrane structure. At the same time, preliminary mechanisms have demonstrated that they can affect the synthesis of ergosterol by inhibiting the activity of dual targets. It is worth noting that they also can exhibit excellent antifungal activity and low toxic side effects in vivo. Their ADMET properties and binding models were established will be useful for further lead optimization.

Construction of antifungal dual-target (SE, CYP51) pharmacophore models and the discovery of novel antifungal inhibitors

Dong, Yue,Liu, Min,Wang, Jian,Ding, Zhuang,Sun, Bin

, p. 26302 - 26314 (2019/09/09)

Fungal infections and drug-resistance are rapidly increasing with the deterioration of the external environment. Squalene cyclooxygenase (SE) and 14α-demethylase (CYP51) are considered to be important antifungal targets, and the corresponding pharmacophore models can be used to design and guide the discovery of novel inhibitors. Therefore, the common feature pharmacophore model (SE inhibitor) and structure-based pharmacophore model (CYP51 receptor) were constructed using different methods in this study. Then, appropriate organic fragments were selected and superimposed onto the pharmacophore features, and compounds 5, 6 and 8 were designed and produced by linking these organic fragments. It is noteworthy that compound 8 can simultaneously match the features of both the SE and CYP51 pharmacophores. Further analysis found that these compounds exhibit a potent antifungal activity. Preliminary mechanistic studies revealed that compound 8 could undergo dual-target inhibition (SE and CYP51) of Candida albicans. This study proved the rationale of pharmacophore models (SE and CYP51), which can guide the design and discovery of new antifungal inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1115-59-9